Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2020, ended Feb 1, 2020 | $16.3B |
| FY2021, ended Jan 30, 2021 | $42.2B |
| FY2022, ended Jan 29, 2022 | $56.2B |
| FY2023, ended Jan 28, 2023 | $37.9B |
| FY2024, ended Feb 3, 2024 | $58.5B |
| FY2025, ended Feb 1, 2025 | $97.7B |
| FY2026, ended Jan 31, 2026 | $69.0B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $164B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2020, ended Feb 1, 2020 | $2.70B |
| FY2021, ended Jan 30, 2021 | $2.97B |
| FY2022, ended Jan 29, 2022 | $4.46B |
| FY2023, ended Jan 28, 2023 | $5.92B |
| FY2024, ended Feb 3, 2024 | $5.51B |
| FY2025, ended Feb 1, 2025 | $5.77B |
| FY2026, ended Jan 31, 2026 | $8.19B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $9.45B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2020, ended Feb 1, 2020 | $1.58B | $278M |
| FY2021, ended Jan 30, 2021 | −$277M | $711M |
| FY2022, ended Jan 29, 2022 | −$421M | $650M |
| FY2023, ended Jan 28, 2023 | −$164M | $1.08B |
| FY2024, ended Feb 3, 2024 | −$933M | $1.03B |
| FY2025, ended Feb 1, 2025 | −$885M | $1.40B |
| FY2026, ended Jan 31, 2026 | $2.67B | $1.40B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $2.64B | $1.73B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2020, ended Feb 1, 2020 | $648M |
| FY2021, ended Jan 30, 2021 | $748M |
| FY2022, ended Jan 29, 2022 | $614M |
| FY2023, ended Jan 28, 2023 | $911M |
| FY2024, ended Feb 3, 2024 | $951M |
| FY2025, ended Feb 1, 2025 | $948M |
| FY2026, ended Jan 31, 2026 | $2.64B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $3.93B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2020, ended Feb 1, 2020 | — |
| FY2021, ended Jan 30, 2021 | $1.39B |
| FY2022, ended Jan 29, 2022 | $4.61B |
| FY2023, ended Jan 28, 2023 | $5.08B |
| FY2024, ended Feb 3, 2024 | $4.27B |
| FY2025, ended Feb 1, 2025 | $4.19B |
| FY2026, ended Jan 31, 2026 | $4.97B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $4.96B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 29.7% since FY20.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2020, ended Feb 1, 2020 | 676M |
| FY2021, ended Jan 30, 2021 | 820M |
| FY2022, ended Jan 29, 2022 | 848M |
| FY2023, ended Jan 28, 2023 | 857M |
| FY2024, ended Feb 3, 2024 | 866M |
| FY2025, ended Feb 1, 2025 | 866M |
| FY2026, ended Jan 31, 2026 | 874M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | 877M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2020, ended Feb 1, 2020 | $364M | $242M | — |
| FY2021, ended Jan 30, 2021 | $25.2M | $242M | — |
| FY2022, ended Jan 29, 2022 | $0 | $461M | $6.89B |
| FY2023, ended Jan 28, 2023 | $115M | $552M | — |
| FY2024, ended Feb 3, 2024 | $150M | $610M | — |
| FY2025, ended Feb 1, 2025 | $725M | $597M | — |
| FY2026, ended Jan 31, 2026 | $2.04B | $591M | — |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2027) | $1.90B | $829M | — |
Valuation
At current price- Market Cap
- $214B
- P/E
- 80.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 22.6×
- Price / Book
- 11.5×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $9.45B
- Revenue Growth YoY
- 30.6%
- Revenue CAGR 3Y
- 11.4%
- Revenue CAGR 5Y
- 22.5%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 52.2%
- Operating Margin
- 16.5%
- Net Margin
- 27.9%
- FCF Margin
- 18.3%
- Return on Equity
- 16.5%
Earnings
Trailing 12 months- Net Income
- $2.64B
- EPS (diluted)
- $3.02
- EBITDA
- —. Operating income + depreciation & amortization
- Operating Income
- $1.56B
Balance Sheet
As of Aug 1, 2026- Cash and cash equivalents
- $3.93B
- Total Debt
- $4.96B
- Net Debt
- $1.03B
- Total Assets
- $27.6B
- Total Liabilities
- $9.02B
- Shareholders' Equity
- $18.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.20B
- Capital Expenditure
- $470M
- Free Cash Flow
- $1.73B
Dividends and risk
Last 12 months- Dividend Yield
- 0.1%
- Dividend / Share
- $0.24
- Beta (5Y)
- 2.25
Every ratio is calculated from the company’s reported figures.